SCHEMBL29475029

SCHEMBL29475029

OC(=CC1=Nc2cc(N3CCOCC3)ccc2C2=NCCN12)c1cncc(O)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPS6KA3 P51812 2/20 0.35
RPS6KA2 Q15349 1/20 0.35
RPS6KA1 Q15418 1/20 0.35
FYN P06241 1/20 0.32
PRKDC P78527 3/20 0.32
PIK3CD O00329 2/20 0.32
PIK3CA P42336 2/20 0.32
PIK3CB P42338 2/20 0.32
PIK3CG P48736 2/20 0.32
LGMN Q99538 2/20 0.32
CDK1 P06493 1/20 0.32
CDK2 P24941 1/20 0.32
PLOD2 O00469 1/20 0.32
PLOD3 O60568 1/20 0.32
PLOD1 Q02809 1/20 0.32
AR P10275 1/20 0.31
MAPT P10636 4/20 0.31
SMN1; SMN2 Q16637 3/20 0.31
NPC1 O15118 3/20 0.31
RAB9A P51151 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL82051 1.00 RPS6KA3 (0.35) RPS6KA3RPS6KA2RPS6KA1FYNPRKDC
SCHEMBL82052 1.00 RPS6KA3 (0.35) RPS6KA3RPS6KA2RPS6KA1FYNPRKDC
SCHEMBL86669 0.87 PLOD2 (0.43) RPS6KA3RPS6KA2RPS6KA1PRKDCPIK3CD
SCHEMBL87428 0.81 SMN1; SMN2 (0.42) PLOD2PLOD3PLOD1MAPTSMN1; SMN2
SCHEMBL29475048 0.78 PIK3CA (0.37) PRKDCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL82608 0.78 PIK3CA (0.37) PRKDCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL82609 0.78 PIK3CA (0.37) PRKDCPIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL81686 0.78 MTOR (0.37) PIK3CAMAPTSMN1; SMN2RAB9AHPGD
SCHEMBL81685 0.78 MTOR (0.37) PIK3CAMAPTSMN1; SMN2RAB9AHPGD
SCHEMBL14041032 0.77 PLOD2 (0.43) RPS6KA3RPS6KA2RPS6KA1PIK3CDPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109729716-B PI3K inhibitor combination 拜耳制药股份公司 2022-03-15 CN disclosed